SCHEMBL19978960

SCHEMBL19978960

CC1(C)OCC23C(O1)[C@@H](CO)O[C@H]2C3n1cnc2c(N)nc(Cl)nc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 6/20 0.55
PDE4D Q08499 2/20 0.52
PDE3A Q14432 2/20 0.52
PNP P00491 1/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
ADORA3 P0DMS8 11/20 0.49
ADORA1 P30542 5/20 0.49
PDE2A O00408 1/20 0.49
ADRA1A P35348 1/20 0.49
HSP90AA1 P07900 1/20 0.43
HSP90B1 P14625 1/20 0.43
PI4KA P42356 1/20 0.41
PI4K2B Q8TCG2 1/20 0.41
PI4K2A Q9BTU6 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19978975 0.88 ADORA2A (0.41) ADORA2APDE4DPDE3APNPLMNA
SCHEMBL19974410 0.84 ADORA2A (0.64) ADORA2APDE4DPDE3APNPLMNA
SCHEMBL22700416 0.84 NT5E (0.45) ADORA2APDE4DPDE3APNPLMNA
SCHEMBL19978965 0.84 NT5E (0.44) ADORA2AADORA3CA1CA2CA4
SCHEMBL22700388 0.78 ADORA2A (0.48) ADORA2APDE4DPDE3APNPLMNA
SCHEMBL22700160 0.75 ADORA2A (0.63) ADORA2APDE4DPDE3APNPLMNA
SCHEMBL572470 0.74 PI4KA (0.72) ADORA2APDE4DPDE3APNPLMNA
SCHEMBL14075797 0.74 PI4KA (0.72) ADORA2APDE4DPDE3APNPLMNA
SCHEMBL19387129 0.74 PI4KA (0.72) ADORA2APDE4DPDE3APNPLMNA
SCHEMBL7202481 0.74 PI4KA (0.72) ADORA2APDE4DPDE3APNPLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512860-B1 NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT LCB PHARMA INC (CA) 2020-11-25 EP disclosed
WO-2018049534-A1 NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT LCB PHARMA INC. (CA) 2018-03-22 WO disclosed